Education
About Us
Working with TipRanks
Follow Us
Addus Homecare (ADUS)
NASDAQ:ADUS
ADUS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$88.96 - $136.72
Previous CloseN/A
Volume20.85K
Average Volume (3M)143.65K
Market Cap
$2.07B
Enterprise Value$2.24B
Total Cash (Recent Filing)$96.95M
Total Debt (Recent Filing)$250.80M
Price to Earnings (P/E)24.9
Beta0.41
Next Earnings
Nov 03, 2025EPS Estimate
1.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.49
Shares Outstanding18,407,240
10 Day Avg. Volume149,414
30 Day Avg. Volume143,651
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.08
Enterprise Value/Revenue1.85
Enterprise Value/Gross Profit5.68
Enterprise Value/Ebitda17.59
Forecast
1Y Price Target
$139.57Price Target Upside26.15% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
Growth StrategyManagement highlighted strong organic growth momentum and important strategic initiatives that are well underway to support growth.
Market OpportunityThe company will benefit from increasing demand driven by an aging population with increased co-morbidities and a continued shift to low-cost site of care settings.
Regulatory ChangesThe Department of Labor's proposed rule could provide a tailwind for home care agencies by reinstating exemptions from federal minimum wage and overtime requirements.
Bears Say
Cost PressuresIn Hospice, ADUS characterized the +2.6% final Medicare rate update as disappointing given that it does not fully reflect increasing cost of care.
Regulatory RisksConcerns around the potential indirect impact from Medicaid cuts as part of the One Big Beautiful Bill have served to pressure the broader healthcare provider space, including ADUS.
Reimbursement PressuresRisks include reimbursement pressures, rising minimum wages, fluctuating employee turnover, and hospice length of stay degradation.
Addus Homecare News
ADUS FAQ
What was Addus Homecare’s price range in the past 12 months?
Addus Homecare lowest stock price was $88.96 and its highest was $136.72 in the past 12 months.
What is Addus Homecare’s market cap?
Addus Homecare’s market cap is $2.07B.
When is Addus Homecare’s upcoming earnings report date?
Addus Homecare’s upcoming earnings report date is Nov 03, 2025 which is in 26 days.
How were Addus Homecare’s earnings last quarter?
Addus Homecare released its earnings results on Aug 04, 2025. The company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.469 by $0.021.
Is Addus Homecare overvalued?
According to Wall Street analysts Addus Homecare’s price is currently Undervalued.
Does Addus Homecare pay dividends?
Addus Homecare does not currently pay dividends.
What is Addus Homecare’s EPS estimate?
Addus Homecare’s EPS estimate is 1.53.
How many shares outstanding does Addus Homecare have?
Addus Homecare has 18,407,240 shares outstanding.
What happened to Addus Homecare’s price movement after its last earnings report?
Addus Homecare reported an EPS of $1.49 in its last earnings report, beating expectations of $1.469. Following the earnings report the stock price went up 8.985%.
Which hedge fund is a major shareholder of Addus Homecare?
Currently, no hedge funds are holding shares in ADUS
Addus Homecare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$139.57 (26.15% Upside)
$139.57 (26.15% Upside)
Blogger Sentiment
Neutral
ADUS Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 1.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $8.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 8.3%
Last 30 Days ▲ 8.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.77%
12-Months-Change
Fundamentals
Return on Equity
8.54%
Trailing 12-Months
Asset Growth
26.19%
Trailing 12-Months
Company Description
Addus Homecare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
ADUS Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue and earnings growth, successful debt reduction, and strategic acquisitions, primarily driven by the Personal Care and Hospice segments. However, challenges were noted in the Home Health segment and concerns over the CMS proposed payment rule impacting future service availability were expressed. Overall, the company showed positive momentum with some areas needing attention.View all ADUS earnings summariesADUS Stock 12 Month Forecast
Average Price Target
$139.57
▲(26.15% Upside)
Technical Analysis
Ownership Overview
2.62% Insiders
34.39% Mutual Funds
34.86% Other Institutional Investors
6.28% Public Companies and
Individual Investors